- GlobeNewswire•23 days agoThreshold Pharmaceuticals Announces Presentation and Webcast at the Stifel Healthcare Conference 2016
SOUTH SAN FRANCISCO, Calif., Nov. 15, 2016-- Threshold Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapies for cancer, today announced that Barry Selick, Ph.D., ...
- Reuters•23 days ago
German drugs and lab supplies maker Merck KGaA lifted its full-year profit forecast on lower overall drug trial costs and as stopping the development of a disappointing cancer drug candidate was less expensive ...
- Associated Press•last month
The South San Francisco, California-based company said it had a loss of 8 cents per share. The company's shares closed at 39 cents. A year ago, they were trading at $4.22. _____ This story was generated ...
THLD : Summary for Threshold Pharmaceuticals, Inc. - Yahoo Finance
Threshold Pharmaceuticals, Inc. (THLD)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||0.42 x 100|
|Ask||0.48 x 1000|
|Day's Range||0.45 - 0.46|
|52 Week Range||0.21 - 1.48|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||0.76|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|